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Acute alcohol administration 
dampens central extended 
amygdala reactivity
Juyoen Hur1, Claire M. Kaplan  1, Jason F. Smith1, Daniel E. Bradford4, Andrew S. Fox5,6, 
John J. Curtin4 & Alexander J. Shackman1,2,3
Alcohol use is common, imposes a staggering burden on public health, and often resists treatment. 
The central extended amygdala (EAc)—including the bed nucleus of the stria terminalis (BST) and the 
central nucleus of the amygdala (Ce)—plays a key role in prominent neuroscientific models of alcohol 
drinking, but the relevance of these regions to acute alcohol consumption in humans remains poorly 
understood. Using a single-blind, randomized-groups design, multiband fMRI data were acquired 
from 49 social drinkers while they performed a well-established emotional faces paradigm after 
consuming either alcohol or placebo. Relative to placebo, alcohol significantly dampened reactivity to 
emotional faces in the BST. To rigorously assess potential regional differences in activation, data were 
extracted from unbiased, anatomically predefined regions of interest. Analyses revealed similar levels 
of dampening in the BST and Ce. In short, alcohol transiently reduces reactivity to emotional faces 
and it does so similarly across the two major divisions of the human EAc. These observations reinforce 
the translational relevance of addiction models derived from preclinical work in rodents and provide 
new insights into the neural systems most relevant to the consumption of alcohol and to the initial 
development of alcohol abuse in humans.
Alcohol use is common (nearly three-quarters of Americans consumed some form of ethanol in the past year and, 
among them, 17.5% met criteria for an alcohol use disorder), contributes to a variety of adverse outcomes, and 
imposes a rapidly growing burden on public health and the economy1–3, highlighting the need to understand the 
acute impact of alcohol consumption on the human brain.
Evidence gleaned from animal models highlights the potential importance of the central extended amygdala 
(EAc), including the bed nucleus of the stria terminalis (BST) and the central nucleus of the amygdala (Ce)4,5 
(Fig. 1). The BST and the Ce show similar patterns of connectivity, cellular composition, neurochemistry, and 
gene expression, and both are critical for triggering defensive responses to threat4,6–9. Through dense projections 
to downstream effector regions, these regions play an important role in prioritizing the processing of salient social 
cues, such as facial expressions of emotion10,11, and shaping social interactions12,13. The EAc also plays a key role in 
prominent neuroscientific models of alcohol-drinking14–18, with work in rodents indicating that alcohol acutely 
dampens EAc reactivity19–23.
The acute impact of alcohol on BST or Ce function in humans remains unclear. To date, imaging research 
has focused on the role of the amygdala proper, with several small-scale studies reporting evidence suggestive of 
dampened reactivity to emotional faces, particularly those expressing fear or anger (Table 1)24–27. None directly 
examined either the BST or the Ce, despite their central role in prominent models of alcohol consumption. Here, 
we used a novel combination of approaches to rigorously assess the impact of acute alcohol consumption on 
EAc reactivity for the first time. Using a single-blind, randomized-groups design and ecologically relevant dos-
ing (Table 2), fMRI data were acquired from 49 psychiatrically healthy social drinkers while they performed an 
fMRI-optimized emotional-faces/places paradigm after consuming alcohol or placebo. The choice of paradigm 
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was rooted in work demonstrating that the amygdala is robustly activated by emotional faces, particularly those 
depicting expressions of fear28–31. This has motivated the use of similar paradigms in work focused on the devel-
opment of anxiety and mood disorders32,33 and the acute impact of alcohol and pharmaceutical (e.g. benzodiaz-
epine) interventions24–27,34,35, as well as large-scale neuroimaging initiatives (e.g., Human Connectome Project, 
UK BioBank)36,37. Several methods served to enhance neuroanatomical resolution, including a multiband pulse 
sequence and advanced co-registration and spatial normalization techniques38 (Table 2). Recently developed, 
anatomically defined regions-of-interest (ROIs)39,40 made it possible to directly compare the hypothesized damp-
ening effects of alcohol in the BST and the Ce in an unbiased manner. Understanding the acute consequences of 
alcohol for EAc function is important. It would clarify whether models of substance abuse derived from work in 
rodents—a species that diverged from the ancestors of modern humans ~75 million years ago41—are relevant to 
human alcohol consumption14,15. It also promises to inform our understanding of work linking variation in EAc 
function to the emergence of alcohol abuse42,43 and to provide insight into the EAc’s role in recreational drinking.
Method
Subjects. A total of 61 individuals between the ages of 21 and 35 years were recruited from the community 
as part of a larger study. All had experience with the highest study dose of alcohol used in the present study 
(~4–5 standard drinks) within the past 12 months, normal or corrected-to-normal color vision, and reported the 
absence of lifetime alcohol or substance-related problems, lifetime neurological symptoms, current psychiatric 
diagnosis or treatment, pervasive developmental disorder or very premature birth, or a medical condition that 
would contraindicate either acute alcohol consumption or MRI. Twelve subjects were excluded from analyses due 
to unusable T1-weighted datasets (n = 3), technical problems with the scanner (n = 1), incidental neurological 
findings (n = 2), inadequate behavioral performance (>2 SDs below the mean; n = 3), or excessive motion artifact 
(n = 3; see below), yielding a final sample of 49 subjects (46.9% female; Table 2 in the main report). All procedures 
were approved by the University of Maryland Institutional Review Board and carried out in accordance with the 
relevant guidelines and regulations. Subjects provided informed written consent.
Overview and General Procedures. Subjects abstained from alcohol and other substances for 24 hours 
and food/drink for 3 hours prior to the session. At the start of the session, initial sobriety was confirmed using a 
standard breath assay (Alcosensor IV Breathalyzer; Intoximeters Inc., St. Louis, MO). Subjects were randomly 
assigned (stratified by sex and race/ethnicity) to receive an alcoholic or placebo beverage, which was consumed 
just prior to scanning. The decision to employ a between-subjects design was motivated by work underscoring 
the relatively low test-retest stability of fMRI measures of amygdala reactivity, which renders it suboptimal for 
randomized cross-over designs44,45. Blood alcohol level (BAL) was assessed immediately before and after scan-
ning. Subject status was continuously monitored using an MRI-compatible eye-tracker. At the end of the session, 
subjects estimated the number of standard alcoholic drinks that they had consumed.
Alcohol/Placebo Procedures. Well-established procedures were used for administering alcohol or placebo46. 
Consistent dosing was achieved using a formula that uses height, weight, age, and sex to produce the target BAL 
of ~0.09% ~30 minutes after the completion of beverage consumption (range: 0.06–0.12%; Table 2)47,48. Alcoholic 
beverages contained a mixture of juice and 100-proof vodka. To control absorption, subjects consumed 3 equal 
doses over 30 minutes. The placebo group received a similar beverage, with distilled water replacing the vodka. 
Subjects assigned to the alcohol (or placebo) group observed the experimenter pouring the vodka (or distilled 
water) from a vodka bottle. The placebo manipulation was reinforced by floating 3 ml of bitters and 3 ml of vodka 
Figure 1. Human EAc. The EAc (magenta) encompasses the BST (encircling the anterior commissure) and the 
Ce (within the dorsal portion of the amygdala proper). The BST and the Ce are anatomically interconnected 
via the ventral amygdalofugal pathway and the stria terminalis, as indicated by deterministic tractography 
(gold). Both regions are poised to orchestrate responses to emotionally salient stimuli via dense projections to 
downstream effector regions. Portions of this figure were adapted from ref.71. Abbreviations—BL, basolateral 
nucleus of the amygdala; BM, basomedial nucleus of the amygdala; BST, bed nucleus of the stria terminalis; Ce, 
central nucleus of the amygdala; La, lateral nucleus of the amygdala; Me, medial nucleus of the amygdala.
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on the surface of the beverage and delivering a minute amount of aerosolized vodka to the rim of the beverage 
containers outside the subject’s view. Immediately following consumption of the third beverage, BAL was assessed 
and subjects were scanned. BAL was re-assessed immediately following the final scan (inter-assessment period: 
M = 70 min, SD = 6.0 min), as in prior work49. On average, subjects in the placebo group estimated that they con-
sumed ~2 drinks, confirming the efficacy of the placebo manipulation (Table 2).
Emotional-Faces/Places Paradigm. To assess the impact of acute alcohol administration on EAc function, 
imaging data were acquired while subjects performed a simple, fMRI-optimized, continuous-performance task. 
Building on work by our group38,50 and many others24–35,51 demonstrating the utility of emotional face paradigms 
for probing amygdala reactivity—particularly when compared to low-level perceptual control stimuli—subjects 
viewed alternating blocks of either emotional faces (8 blocks) or places (9 blocks). The use of a block design 
enhances detection power and mitigates potential concerns about alcohol-induced changes in the shape of the 
hemodynamic response function (HRF)52,53. Block length (~16.3 s) was also optimized to detect differential blood 
oxygen level-dependent (BOLD) signals across the two conditions52,53. To maximize signal strength and homo-
geneity and minimize potential neural habituation52–54, each block consisted of 16 brief presentations of faces 
Study
N
(% Male)
EPI Voxel 
Size (mm3) Normalizationa Design Task Amygdala Results
Present study 49 (53%) 8.0
FSL (BBR) 
and ANTS 
(diffeomorphic)
Single-blind, 
placebo-controlled, 
randomized groups
Fearful/Neutral 
Faces vs. Places 
(blocked)
See the main report
Gilman 2008 12 (42%) 70.3 “AFNI” (affine?)
Double-blind, 
placebo-controlled, 
randomized cross-over
Fearful vs. Neutral 
Faces (event-
related)
Voxelwise
a. Expression × Treatment, NS
b. Expression during Placebo: Fearful > Neutral, p < 0.05, corrected
c. Expression during Alcohol: Fearful vs. Neutral, NS
ROI
a. Expression × Treatment, p = 0.08
b. Expression during Placebo: Fearful > Neutral, p < 0.05
c. Expression during Alcohol: Fearful vs. Neutral, NS
Gilman 2012b 14 (100%) 70.3 “AFNI” (affine?)
Double-blind, 
placebo-controlled, 
randomized cross-over
Fearful vs. Neutral 
Faces (event-
related)
Voxelwise
a. Expression × Treatment, NR
b. Expression during Placebo: Fearful > Neutral, p < 0.01, corrected
c. Expression during Alcohol: Fearful vs. Neutral, NS
ROI
a. Expression × Treatment, p = 0.02
b. Treatment for Neutral: NR
c. Treatment for Fearful: Alcohol < Placebo, p = 0.02
Padula 2011c 12 (58%) 58.8 “AFNI” (affine?)
Single-blind, 
placebo-controlled, 
randomized cross-over
Angry/Fearful/
Happy Faces vs. 
Shapes (blocked)
Voxelwise
a. Stimulus × Treatment, NS
b. Stimulus during Placebo: Faces > Shapes, p < 0.05, corrected
c. Stimulus during Alcohol: Faces vs. Shapes, NS
Sripada 2011 12 (83%) 70.3 SPM12 (EPI template)
Double-blind, 
placebo-controlled, 
randomized cross-over
Fearful/Angry 
vs. Happy Faces 
(blocked)
Voxelwise
a. Expression × Treatment, NS
b.  Expression during Placebo: Fearful/Angry > Happy, p < 0.005, 
uncorrected
c. Expression during Alcohol: Fearful/Angry vs. Happy, NS
d.  Treatment during Fearful/Angry: Alcohol < Placebo, p < 0.005, 
uncorrected
d. Treatment during Happy: NR
ROI
a. Expression × Treatment, NR
b. Expression during Placebo: Fearful/Angry > Happy, p < 0.05
c. Expression during Alcohol: Alcohol < Placebo, NS
Table 1. The effects of acute alcohol administration on amygdala reactivity in human imaging studies. aOlder 
normalization techniques (e.g., affine, EPI-to-EPI) can introduce substantial spatial smoothing and registration 
error, which is a concern for work focused on small subcortical structures, such as the EAc. bSocial drinker 
(‘control’) group. cROI analyses were not reported. Abbreviations—BBR, boundary-based registration of the T1- 
and T2-weighted images; NR, not reported; NS, not significant.
Total Placebo Alcohol Difference
Sample size 49 22 27 N/A
Mean Age in Years (SD) 22.4 (2.5) 22.1 (1.4) 22.6 (3.1) t(47) = 0.69, p = 0.50
Gender: Female/Male 23/26 11/11 12/15 χ2 = 0.15, p = 0.8
Mean BALa (SD) N/A 0.00 (0.00) 0.09 (0.02) t(47) = 27.20, p < 0.001
Mean Subjective Estimate of Number of Drinks 
Consumed During the Study (SD) N/A 2.07 (1.09)
b 4.56 (1.25)c t(47) = 7.32, p < 0.001
Mean Motion, Frame-to-Frame Displacement (SD) 0.13 (0.03) 0.12 (0.03) 0.13 (0.03) t(47) = 1.01, p = 0.32
Table 2. Demographic variables and descriptive statistics for the placebo and alcohol groups. aPre-MRI 
and post-MRI BAL were strongly correlated, r(47) = 0.96, p < 0.001. bWithin-group difference from zero, 
t(21) = 8.87, p < 0.001. cWithin-group difference from zero, t(26) = 18.93, p < 0.001.
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or places (~1.02 s/image). During face blocks, subjects discriminated (two-alternative/forced-choice) between 
fearful (75% trials) and emotionally neutral facial expressions (25% trials) presented in a pseudorandomized 
order. This design choice was aimed at reducing monotony and minimizing potential habituation of the amyg-
dala54. Face stimuli were adapted from prior work by Gamer and colleagues55,56 and included standardized images 
of unfamiliar male and female adults displaying unambiguous fearful or neutral expressions. To maximize the 
number of models and mitigate potential habituation, images were derived from several well-established data-
bases: Ekman and Friesen’s Pictures of Facial Affect57, the FACES database58, the Karolinska Directed Emotional 
Faces database (http://www.emotionlab.se/resources/kdef), and the NimStim Face Stimulus Set (https://www.
macbrain.org/resources.htm). Color images were converted to grayscale, brightness normalized, and masked 
to occlude non-facial features (e.g., ears, hair). During place blocks, subjects discriminated between suburban 
residential buildings (i.e. houses; 75%) and urban commercial buildings (i.e. skyscrapers; 25%). Grayscale place 
stimuli were adapted from prior work59,60. Responses were made using an MRI-compatible, fiber-optic response 
pad (MRA, Washington, PA).
MRI Data Acquisition. MRI data were acquired using a Siemens Magnetom TIM Trio 3 Tesla scanner and 
32-channel head-coil. Sagittal T1-weighted anatomical images were acquired using a MPRAGE sequence 
(TR = 1,900 ms; TE = 2.32 ms; inversion time = 900 ms; flip angle = 9°; sagittal slice thickness = 0.9 mm; 
in-plane = 0.449 × 0.449 mm; matrix = 512 × 512; field-of-view = 230 × 230). To enhance resolution, a 
multi-band sequence was used to collect a total of 286 oblique-axial echo planar imaging (EPI) volumes during 
the faces/places task (multiband acceleration = 6; TR = 1,000 ms; TE = 39.4 ms; flip angle = 36.4°; slice thick-
ness = 2.2 mm, number of slices = 60; in-plane resolution = 2.1875 × 2.1875 mm; matrix = 96 × 96). Images were 
collected in the oblique axial plane (approximately −20° relative to the AC-PC plane) to minimize susceptibility 
artifacts. To enable fieldmap correction, two oblique-axial spin echo (SE) images were collected in each of two 
opposing phase-encoding directions (rostral-to-caudal and caudal-to-rostral) at the same location and resolution 
as the functional volumes (i.e., co-planar; TR = 7,220 ms; TE = 73 ms).
MRI Data Preprocessing. Given our focus on the EAc, methods were optimized to minimize spatial normaliza-
tion error and other potential sources of noise. All MRI data were visually inspected before and after processing 
for quality assurance purposes.
Anatomical Data Processing: Methods are similar to those described in other recent reports by our group38,40. 
T1 images were brain-extracted (‘skull-stripped’) using a multi-tool approach40. Brain-extracted T1 images were 
normalized to the MNI152 template using the high-precision diffeomorphic approach implemented in SyN61. The 
mean of the normalized T1 images is depicted in Supplementary Figure S1. FSL was used to create a fieldmap and 
undistorted SE image.
Functional Data Processing: The first 3 volumes of each EPI scan were removed. Remaining volumes were 
de-spiked and slice-time corrected using AFNI62. For co-registration of the functional and anatomical images, 
an average EPI image was created. The average image was simultaneously co-registered with the corresponding 
T1-weighted image in native space and corrected for geometric distortions using the boundary-based registration 
method implemented in FSL and the previously created fieldmap, undistorted SE image, and T1 image. Spatial 
transformations were concatenated and applied to the functional data in a single step. The transformed images 
were re-sliced (2-mm3), smoothed (6-mm), and filtered (0.0078125-Hz high-pass). To assess residual motion 
artifact, the variance of volume-to-volume displacement of a selected voxel in the center of the brain (x = 5, 
y = 34, z = 28) was calculated using the motion-corrected EPI data. Subjects (n = 3) with extreme motion variance 
(>2SDs above the mean) were excluded from analyses.
fMRI Modeling: At the first level (single-subject), the emotional-faces/places task was modeled using a boxcar 
function with place blocks serving as the implicit baseline63. Block onsets were modeled as nuisance variates using 
two additional event-related predictors. All predictors were convolved with a canonical HRF. Prior research in 
relatively large samples has failed to uncover alcohol-induced changes in EAc blood flow, mitigating concerns 
about gross hemodynamic differences64. Additional nuisance variates included motion and physiological noise 
estimates. To attenuate physiological noise, white matter (WM) and cerebrospinal fluid (CSF) time-series were 
identified by thresholding the tissue prior images distributed with FSL. The EPI time-series was orthogonalized 
with respect to the first 3 right eigenvectors of the data covariance matrix from the WM and CSF compartments65.
Reactivity to emotional faces (i.e., the main effect of Stimulus: Emotional Faces vs. Places) was assessed using a 
voxelwise one-sample t test controlling for potential nuisance variance in mean-centered age and sex. The impact 
of alcohol administration was assessed using a voxelwise two-sample t test controlling for mean-centered age and 
sex, equivalent to testing the Stimulus (Emotional Faces vs. Places) × Treatment (Alcohol vs. Placebo) interaction.
Hypothesis Testing Strategy. The major aim of the study was to test the hypothesized dampening effects of acute 
alcohol administration on EAc reactivity to emotional faces.
EAc Region-of-Interest (ROI) Analyses: The Stimulus × Treatment interaction was rigorously thresholded 
at p < 0.05 familywise error (FWE) corrected for the extent of the EAc ROI, as in prior work by our group66. 
The EAc ROI encompassed the amygdala, substantia innominata/sublenticular extended amygdala (SI/
SLEA), and BST bilaterally40,67. Consistent with recent recommendations4,6, the ROI was created using the Mai 
and Harvard-Oxford atlases68–72 and included the probabilistic BST ROI developed by Theiss and colleagues 
(p > 0%)39 and the Harvard-Oxford probabilistic amygdala. Using this as a starting point, voxels in the region of 
the SI/SLEA was manually added in the coronal plane of the 1-mm MNI152 template, working from rostral to 
caudal, and confirmed in the other planes. At intermediate levels of the amygdala’s rostral-caudal axis, where the 
BST was no longer visible, the SI/SLEA was limited to voxels dorsal to the amygdala and ventral to the putamen 
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and pallidum. SI/SLEA voxels were included until the head of the hippocampus was clearly visible. Voxels in 
neighboring regions of the accumbens, caudate, putamen, pallidum, thalamus, and ventricles (Harvard-Oxford 
atlas, p > 50%) were excluded using a Boolean ‘NOT.’ The resulting bilateral EAc ROI was decimated to 2-mm3 
(Supplementary Figure S2; total: 1,205 voxels; 9,640 mm3). Significant clusters (p < 0.05, whole-brain FWE cor-
rected) outside the EAc are reported on an exploratory basis for voxelwise analyses of the Condition (Emotional 
Faces vs. Places) and Stimulus × Treatment effects.
Unbiased Comparison of the BST and Ce: In order to test the whether the BST and the Ce differ in their 
sensitivity to the hypothesized dampening effects of alcohol in an unbiased manner, we extracted and averaged 
standardized contrast coefficients using anatomically defined, a priori ROIs39,40 (Supplementary Figure S3). A 
general linear model was used to compare the impact of Treatment and Hemisphere on regional reactivity to 
emotional faces. Significant interactions were decomposed using simple effects. The Group effect is reported 
using the Welch-Satterthwaite correction (FW-S). A power analysis revealed that a minimum of 44 subjects is 
required to achieve 95% power to detect a Stimulus × Treatment interaction with a between-subjects design (as 
in the present study) and an estimated effect size of Cohen’s d = 1.13 (reported in ref.25) at p < 0.05, uncorrected.
Results
Behavior. On average, subjects were highly accurate at performing the simple discrimination tasks 
(M = 86.8%, SD = 7.9). Nevertheless, performance was ~8% lower in the alcohol (M = 83.2%, SD = 8.2) compared 
to the placebo group (M = 91.1%, SD = 4.9; FW-S(1,47) = 15.98, p < 0.001), consistent with prior work73. Subjects 
were ~4% more accurate when performing the places (M = 88.8%, SD = 8.8) compared to the faces discrimi-
nation (M = 84.4%, SD = 8.4; F(48) = 22.37, p < 0.001), but the Group × Condition interaction was not reliable 
(F(1,47) = 0.24, p = 0.63). As noted below, control analyses indicated that these modest differences in perfor-
mance were not the primary determinant of alcohol-related differences in neural reactivity.
The Dorsal Amygdala is Sensitive to Emotional Faces. Within the EAc, emotional faces were associated 
with significant activation of the dorsal amygdala, bilaterally (p < 0.05, FWE-corrected; Left: t = 12.59, vol-
ume = 1,032 mm3; x = −20, y = −10, z = −14; Right: t = 12.22, volume = 1,368 mm3; x = 22, y = −8, z = −16; 
Fig. 2a and Supplementary Table S1), consistent with prior work10. As shown in Supplementary Figure S4, the 
amygdala cluster overlapped the anatomically defined Ce ROI, with the left and right peaks lying in the dorsocau-
dal region where the Ce, medial, and basomedial nuclei abut.
On an exploratory basis, we also computed a series of whole-brain analyses. Results indicated that the dor-
sal amygdala and fusiform cortex (‘fusiform face area’) were significantly more sensitive to emotional faces, 
whereas the parahippocampal cortex (‘parahippocampal place area’) was significantly more sensitive to places, as 
expected74,75 (p < 0.05, FWE-corrected; Supplementary Figure S5 and Supplementary Table S2).
Alcohol Dampens BST Reactivity. Within the EAc, acute alcohol administration was associated with a signifi-
cant reduction in left BST reactivity to emotional faces (Stimulus × Treatment: p < 0.05, FWE-corrected; t = 5.46, 
volume = 104 mm3; x = −8, y = −2, z = 0; Fig. 2b–c and Supplementary Table S3). As shown in Supplementary 
Figure S6, the left BST cluster overlapped the anatomically defined BST ROI. The Stimulus × Treatment interac-
tion was not significant in the amygdala at this threshold. Exploratory whole-brain analyses revealed no addi-
tional clusters. Control analyses performed using a performance-matched sub-sample (n = 15/group) yielded 
similar results, suggesting that the dampening effects of alcohol on BST reactivity are not due to group differences 
in performance.
Alcohol Exerts Similar Effects in the Ce and the BST. To assess potential regional differences in EAc activation 
in an unbiased manner76, standardized contrast coefficients (i.e., emotional faces vs. places) were extracted from 
the left and right BST and Ce using anatomically defined, a priori ROIs, as shown in the upper portion of Fig. 3 
(Ce: cyan; BST: green). A mixed-model GLM was then used to compare the impact of Treatment and Hemisphere 
on regional reactivity to emotional faces. Analyses revealed greater activation to faces in the Ce compared to the 
BST (Region: F(1,47) = 32.99, p < 0.001), consistent with recent high-resolution imaging research77. Analyses also 
revealed a significant alcohol-dampening effect across regions (Group: FW-S(1,47) = 3.93, p = 0.05). Other omni-
bus effects were not significant (ps > 0.15). Control analyses performed using a performance-matched sub-sample 
yielded similar results. Collectively, these observations indicate that alcohol acutely dampens EAc reactivity to 
emotional faces, it does so similarly in the BST and Ce, and these effects are not an artifact of group differences 
in task engagement.
Discussion
Recent epidemiological work indicates that the United States is facing a growing alcohol use crisis78, yet the neural 
circuitry most relevant to human alcohol consumption has remained unclear. Leveraging a placebo-controlled, 
randomized-groups design, our voxelwise results demonstrate for the first time that alcohol acutely dampens BST 
reactivity to emotional faces (Fig. 2). Analyses performed using unbiased, anatomically defined ROIs revealed 
similar patterns of reduced reactivity in the BST and the Ce (Fig. 3). Control analyses indicated that these results 
were not an artifact of group differences in performance. Collectively, these findings indicate that acute alcohol 
intoxication dampens reactivity to emotional faces and it does so similarly across the major divisions of the EAc.
The present findings are broadly consistent with models of alcohol drinking derived from preclinical research 
in mice and rats14–17. This work strongly implicates both divisions of the EAc in the anxiety-reducing conse-
quences of alcohol19,23. Alcohol robustly engages the BST and the Ce, as indexed by elevated expression of the 
immediate early gene c-fos20. Acute alcohol consumption is associated with reduced behavioral signs of anxiety 
and increased c-fos induction in the BST and Ce21. While the molecular consequences of alcohol are complex, 
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alcohol acutely inhibits excitatory (i.e., glutamatergic) neurotransmission across the EAc and increases inhibitory 
(i.e., GABA) neurotransmission in the Ce79–81. Other work indicates that EAc microcircuits play a critical role 
in excessive drinking82,83, consistent with evidence implicating the EAc in withdrawal-induced signs of anxiety 
Figure 2. The impact of acute alcohol administration on reactivity to emotional faces in the central extended 
amygdala. (a) Consistent with prior work, voxelwise regression analyses revealed significant activation to 
emotional faces in the dorsal amygdala (p < 0.05, FWE corrected for the volume of the anatomically defined 
EAc region-of-interest; total volume: 1,205 voxels; 9,640 mm3). Inset indicates the location of the coronal slice. 
Significant clusters within the EAc ROI (Supplementary Figure S2) are depicted here. For additional results, 
see Supplementary Figures S4 and S5 and Supplementary Tables S1 and S2. (b) Voxelwise analyses revealed a 
significant reduction in reactivity to emotional faces in the region of the left BST in the alcohol compared to the 
placebo group (same threshold; equivalent to testing the Stimulus × Treatment interaction). The left half of the 
panel depicts the BST cluster. The right half depicts the BST (green) in the corresponding section of the human 
brain atlas71. Note the similar appearance of several key landmarks, including the fornix and lateral ventricle 
(white), as well as the optic tract and anterior commissure (gold). Upper left inset indicates the location of the 
coronal slice. Upper right inset depicts the myeloarchitecture (Weigert fiber stain) of this region in the atlas. 
The left BST was the only significant cluster in EAc-focused or whole-brain analyses. For additional results, 
see Supplementary Figure S6 and Supplementary Table S3. (c) For illustrative purposes, barplot depicts mean 
standardized regression coefficients extracted from the peak voxel in the BST cluster for the alcohol (light 
green) and placebo (dark green) groups. Hypothesis testing was performed on a voxelwise basis (corrected for 
multiple comparisons). Error bars indicate the standard error of the mean. Portions of this figure were adapted 
with permission from ref.71. Abbreviations—ac, anterior commissure; BST, bed nucleus of the stria terminalis; 
Cd, caudate; EAc, central division of the extended amygdala; FWE, family-wise error; fx, fornix; GPe, external 
globus pallidus; GPi, internal globus pallidus; L, left hemisphere; LV, lateral ventricle; OT, optic tract; Pu, 
putamen; R, right hemisphere; SVC, small volume correction.
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and stress-induced substance use14. Although these observations highlight the importance of specific cell types 
and circuits within and between the Ce and BST for alcohol consumption in rodents, the relevance of these dis-
coveries to human drinking and disease has remained unclear. The present results, which underscore the similar 
consequences of acute alcohol consumption across the EAc, increase our confidence that the pathways identified 
in rodent models are broadly conserved across species and can guide the development of improved treatments84. 
The development of integrative animal models that combine focal perturbations of the EAc with the same kinds 
of paradigms and imaging techniques routinely used in human studies would allow a more complete and detailed 
synthesis of these distinct bodies of research4,85.
Future Challenges. Although the present study affords new insights into the acute impact of alcohol 
on the human brain, several limitations and challenges merit comment. First, while single-blind designs are 
routinely used in acute alcohol challenge studies86, use of a double-blind design would eliminate potential 
experimenter-expectancy biases. Second, the present study used static images of fearful (75%) and emotionally 
neutral (25%) faces to probe EAc reactivity. Although fearful faces do not elicit robust signs of fear or anxiety10 
(e.g. potentiation of the startle reflex) and are less ecologically valid than dynamic expressions of emotion87, they 
are widely used in neuroimaging research, rated as more threatening and arousing than neutral or happy faces, 
and associated with increased behavioral caution88–91. Fearful faces also promote vigilance; the mere presentation 
of fearful faces produces persistent increases in visual sensitivity, boosts the resolution of visual processing, and 
enhances the efficiency of attentional search10. Vigilance is thought to be mediated by circuits emanating from the 
EAc11 and, once elicited, increases the likelihood of experiencing more extreme or pervasive states of distress10,92. 
Notably, recent neuroimaging research indicates that individuals with elevated amygdala reactivity to fearful 
faces are more likely to abuse alcohol in the future, during and following exposure to negative life events (e.g. 
significant academic, financial, health, or relationship problems)42,43. The present results reinforce the possibility 
that this prospective association reflects attempts to downregulate, normalize, or self-medicate neural circuits 
centered on the EAc. Testing this hypothesis is an important challenge for future research. Assessing whether 
our conclusions generalize to more intense cues, such as threat-of-shock, represents another important avenue. 
The use of stimuli that elicit robust signs of anxiety (e.g. startle potentiation) would dovetail with work in rodent 
models, enhancing the likelihood of successful bi-directional translation85,93. Combined with more naturalistic 
measures of stress-induced drinking in the laboratory or field (e.g., using ecological momentary assessment), this 
approach might provide a means of stratifying at-risk populations or patients into the subset for whom negative 
reinforcement circuits are most relevant to intervention.
Conclusions. Existing treatments for excessive alcohol consumption are far from curative94,95, highlighting 
the need for a deeper understanding of the underlying neural and motivational systems. The present results 
demonstrate that alcohol acutely dampens EAc reactivity in humans, providing an important source of validation 
for models of alcohol drinking derived from preclinical research in rodents. The use of a relatively large sample, 
placebo-controlled between-groups design, ecologically relevant dosing, fMRI-optimized task, best practices for 
the acquisition and processing of functional neuroimaging data, and unbiased ROI analytic approach enhances 
our confidence in the clinical and translational significance of these results. More broadly, these observations 
provide insights into some of the neural systems most relevant to the consumption of alcohol and the initial 
development of alcohol abuse in humans.
Figure 3. The impact of acute alcohol administration on the two major divisions of the EAc. Barplot depicts 
mean regression coefficients associated with the emotional-faces/places task for the anatomically defined Ce 
and BST ROIs for each group. The Ce was significantly more reactive to emotional faces, relative to the BST 
(p < 0.001). On average, subjects randomly assigned to the alcohol group showed significantly less reactivity to 
emotional faces, relative to those in the placebo group (p = 0.05; equivalent to testing the Stimulus × Treatment 
interaction). The Treatment × Region interaction was not significant (p = 0.88), suggesting that the Ce and 
BST are similarly sensitive to acute alcohol dampening. Error bars indicate the standard error of the mean. 
Abbreviations—EAc, central extended amygdala; ROI, region of interest.
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Data Availability
Key statistical maps and regions-of-interest are available at NeuroVault.org (http://neurovault.org/collec-
tions/4414/).
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